Clinical Trial Update: Intravenous Versus Intracoronary Use of Abciximab [NA]

View source ↗

Summary

A completed clinical trial comparing intravenous versus intracoronary administration of abciximab in patients with atherosclerosis and ischemic heart disease. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Ischemic Heart Disease

Drugs mentioned

• Abciximab (abciximab)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Atherosclerosis, Ischemic Heart Disease | NA | Status: COMPLETED